Alzheimer's Disease in Down Syndrome: From Molecules to Cognition
Conference - Hinxton, Cambridge, United Kingdom
This new Wellcome Trust conference will focus on understanding the links between Down syndrome and Alzheimer's disease. With the Down syndrome population now approaching eight million, it is important to understand the nature and cause of the AD-like dementia that can occur in this disease. Our aim is to understand dementia in Down syndrome at the neurological, cognitive, behavioural, cellular and genetic levels, which will also inform our general understanding of Alzheimer's disease.
This multi-disciplinary meeting will focus on the development of biomarkers for early diagnosis of dementia in Down syndrome, the biochemical and cellular characteristics that differentiate those who will develop dementia from those who are protected, the genetics of behavioural and cognitive phenotypes seen in Alzheimer's disease and Down syndrome, and stem cell approaches to therapies for dementia. Panel discussions will be arranged on aspects of clinical studies in Alzheimer's disease and Down syndrome
Scientific sessions
Clinical studies in Alzheimer's disease and Down syndrome
Developmental studies in Down syndrome: early markers for Alzheimer's disease?
Animal models
Cell modelling in dementia
Genetics and informatics
Organization: Wellcome Trust
(Courtesy of Wellcome Trust Genome Campus, Hinxton, Cambridge, UK, via predictconsortium.eu)
Alzheimer's Disease in Down Syndrome: From Molecules to Cognition
Thu, Mar 27, 2014 - Sat, Mar 29, 2014
Wellcome Trust Genome Campus
Hinxton, Cambridge, United Kingdom
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
